stock
Sarepta Therapeutics Inc
NASDAQ | SRPT
20.30
USD
0.00 ( 0.00%)
AT CLOSE (AS OF Jun 16, 2025)
$3.6B
MARKET CAP
-
P/E Ratio
-2.64
EPS
$173
52 Week High
$34
52 Week Low
LIFE SCIENCES
Sector
SRPT Chart
Recent Chart
Price Action
1D
Candles
Trade Smarter
Automate your trading workflow with powerful tools — built for serious traders.
SRPT Technicals
SRPT Earnings
Yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $1.6B |
| Total Revenue | $1.9B |
| Cost Of Revenue | $319M |
| Costof Goods And Services Sold | $319M |
| Operating Income | $218M |
| Selling General And Administrative | $558M |
| Research And Development | $805M |
| Operating Expenses | $1.4B |
| Investment Income Net | - |
| Net Interest Income | $53M |
| Interest Income | $72M |
| Interest Expense | $18M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $54M |
| Income Before Tax | $261M |
| Income Tax Expense | $26M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $235M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $279M |
| Ebitda | $333M |
| Net Income | $235M |
Revenue & Profitability
Earnings Performance
SRPT Financials
yearly Balance Sheet (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Total Assets | $4B |
| Total Current Assets | $3.1B |
| Cash And Cash Equivalents At Carrying Value | $1.1B |
| Cash And Short Term Investments | $1.1B |
| Inventory | $750M |
| Current Net Receivables | $650M |
| Total Non Current Assets | $890M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $27M |
| Intangible Assets Excluding Goodwill | $27M |
| Goodwill | - |
| Investments | - |
| Long Term Investments | $137M |
| Short Term Investments | $252M |
| Other Current Assets | $319M |
| Other Non Current Assets | - |
| Total Liabilities | $2.4B |
| Total Current Liabilities | $732M |
| Current Accounts Payable | $214M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $13M |
| Total Non Current Liabilities | $1.7B |
| Capital Lease Obligations | $206M |
| Long Term Debt | $1.1B |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $1.3B |
| Other Current Liabilities | $370M |
| Other Non Current Liabilities | $49M |
| Total Shareholder Equity | $1.5B |
| Treasury Stock | - |
| Retained Earnings | -$4.2B |
| Common Stock | $10K |
| Common Stock Shares Outstanding | $108M |
yearly Cash Flow (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$206M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $38M |
| Capital Expenditures | $137M |
| Change In Receivables | - |
| Change In Inventory | -$395M |
| Profit Loss | - |
| Cashflow From Investment | - |
| Cashflow From Financing | $125M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | $235M |
yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $1.6B |
| Total Revenue | $1.9B |
| Cost Of Revenue | $319M |
| Costof Goods And Services Sold | $319M |
| Operating Income | $218M |
| Selling General And Administrative | $558M |
| Research And Development | $805M |
| Operating Expenses | $1.4B |
| Investment Income Net | - |
| Net Interest Income | $53M |
| Interest Income | $72M |
| Interest Expense | $18M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $54M |
| Income Before Tax | $261M |
| Income Tax Expense | $26M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $235M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $279M |
| Ebitda | $333M |
| Net Income | $235M |
SRPT News
SRPT Profile
Sarepta Therapeutics Inc Profile
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company is headquartered in Cambridge, Massachusetts.
GNLN 13.86%
$0.0115
HCTI 25.12%
$0.0254
DNN 11.82%
$1.845
SRM 524.13%
$9.0499
NCNA 18.28%
$0.1359
NVDA 2.22%
$145.125
LCID 4.76%
$2.2
SONM 77.46%
$1.65
CGBS -13.69%
$0.0971
BTE -3.35%
$2.02
KULR -21.28%
$0.9053
AMD 9.65%
$127.37
MLGO -29.09%
$0.6099
CREG -35.99%
$0.37
AXDX -61.36%
$0.034
TSLA 1.02%
$328.6211
PLTR 4.13%
$143.075
TMDE
64.89%
$2.16
INTC 3.05%
$20.755
OP 37.89%
$2.22
LYT -16.78%
$0.0982
BTG -2.42%
$3.6788
BNZI 5.26%
$0.6126
NEHC 7.64%
$0.5847
SKYQ 3.67%
$0.7819
TDTH 19.24%
$0.2516
JWN 0.08%
$24.66
F 1.87%
$10.625
QBTS 5.11%
$15.945
PLUG 2.93%
$1.3278
QUBT 25.30%
$20.9006
SOFI 4.86%
$14.775
DWSN 117.51%
$2.9799
NVTS 0.20%
$7.335
AAL 5.21%
$10.91
SBET 48.26%
$13.6551
ACHR 2.79%
$10.2687
BATL 56.71%
$2.57
WLGS -18.57%
$0.0557
SHOT 8.63%
$0.2619
RGTI 4.90%
$11.9582
RIG -3.01%
$3.22
ABEV -0.20%
$2.435
CRCL
15.82%
$154.69
SRPT -43.73%
$20.36
HIMS 5.70%
$58.64
BBD 3.02%
$3.07
RIOT 3.00%
$10.0115
VALE 3.72%
$9.8118
OKLO -1.27%
$63.66
APLD 2.42%
$11.45
DFS -0.21%
$200.05
ME -21.26%
$0.6063
CUTR -10.19%
$0.0969
MARA 1.47%
$15.2614
WBD 5.68%
$10.6001
WULF 7.22%
$4.3103
SNAP 3.34%
$8.205
PBR 0.50%
$12.764
SMCI 5.40%
$43.805
PCSA -10.14%
$0.2323
AAPL 0.76%
$197.948
SAGE 35.67%
$9.09
UEC 7.34%
$6.7088
AFMD -34.95%
$0.1815
IONQ 1.35%
$38.35
STAK 31.02%
$2.5548
CAN 3.53%
$0.6895
SOUN 6.04%
$9.65
CLSK 2.10%
$9.495
PFE -0.73%
$24.3615
CTLP 15.74%
$10.995
CCL 5.80%
$23.7095
NGD -0.92%
$4.865
RXRX 3.05%
$5.07
CLF 3.42%
$7.415
GME 4.70%
$23.18
VHAI 0.00%
$0.0006
HOOD 5.04%
$76.2615
GRAB 3.17%
$4.715
PCG -0.67%
$13.5484
CIFR 4.99%
$3.9058
BAC 1.00%
$44.5288
MP 12.98%
$34.515
AMZN 1.65%
$215.596
CRML 44.83%
$2.94
BERY -2.93%
$67.58
KGC -1.55%
$15.5458
TMC 25.78%
$5.4588
BRN 1.11%
$1.7897
UUUU 3.65%
$5.825
GOOGL 0.73%
$175.945
AG -1.38%
$8.225
COTY 6.45%
$5.035
MVIS 12.96%
$1.22
ORCL -2.11%
$210.6846
JOBY 3.95%
$8.94
RUN -7.95%
$9.205
CRWV
6.55%
$156.825
RIVN 3.32%
$13.865
GNLN 13.86%
$0.0115
HCTI 25.12%
$0.0254
DNN 11.82%
$1.845
SRM 524.13%
$9.0499
NCNA 18.28%
$0.1359
NVDA 2.22%
$145.125
LCID 4.76%
$2.2
SONM 77.46%
$1.65
CGBS -13.69%
$0.0971
BTE -3.35%
$2.02
KULR -21.28%
$0.9053
AMD 9.65%
$127.37
MLGO -29.09%
$0.6099
CREG -35.99%
$0.37
AXDX -61.36%
$0.034
TSLA 1.02%
$328.6211
PLTR 4.13%
$143.075
TMDE
64.89%
$2.16
INTC 3.05%
$20.755
OP 37.89%
$2.22
LYT -16.78%
$0.0982
BTG -2.42%
$3.6788
BNZI 5.26%
$0.6126
NEHC 7.64%
$0.5847
SKYQ 3.67%
$0.7819
TDTH 19.24%
$0.2516
JWN 0.08%
$24.66
F 1.87%
$10.625
QBTS 5.11%
$15.945
PLUG 2.93%
$1.3278
QUBT 25.30%
$20.9006
SOFI 4.86%
$14.775
DWSN 117.51%
$2.9799
NVTS 0.20%
$7.335
AAL 5.21%
$10.91
SBET 48.26%
$13.6551
ACHR 2.79%
$10.2687
BATL 56.71%
$2.57
WLGS -18.57%
$0.0557
SHOT 8.63%
$0.2619
RGTI 4.90%
$11.9582
RIG -3.01%
$3.22
ABEV -0.20%
$2.435
CRCL
15.82%
$154.69
SRPT -43.73%
$20.36
HIMS 5.70%
$58.64
BBD 3.02%
$3.07
RIOT 3.00%
$10.0115
VALE 3.72%
$9.8118
OKLO -1.27%
$63.66
APLD 2.42%
$11.45
DFS -0.21%
$200.05
ME -21.26%
$0.6063
CUTR -10.19%
$0.0969
MARA 1.47%
$15.2614
WBD 5.68%
$10.6001
WULF 7.22%
$4.3103
SNAP 3.34%
$8.205
PBR 0.50%
$12.764
SMCI 5.40%
$43.805
PCSA -10.14%
$0.2323
AAPL 0.76%
$197.948
SAGE 35.67%
$9.09
UEC 7.34%
$6.7088
AFMD -34.95%
$0.1815
IONQ 1.35%
$38.35
STAK 31.02%
$2.5548
CAN 3.53%
$0.6895
SOUN 6.04%
$9.65
CLSK 2.10%
$9.495
PFE -0.73%
$24.3615
CTLP 15.74%
$10.995
CCL 5.80%
$23.7095
NGD -0.92%
$4.865
RXRX 3.05%
$5.07
CLF 3.42%
$7.415
GME 4.70%
$23.18
VHAI 0.00%
$0.0006
HOOD 5.04%
$76.2615
GRAB 3.17%
$4.715
PCG -0.67%
$13.5484
CIFR 4.99%
$3.9058
BAC 1.00%
$44.5288
MP 12.98%
$34.515
AMZN 1.65%
$215.596
CRML 44.83%
$2.94
BERY -2.93%
$67.58
KGC -1.55%
$15.5458
TMC 25.78%
$5.4588
BRN 1.11%
$1.7897
UUUU 3.65%
$5.825
GOOGL 0.73%
$175.945
AG -1.38%
$8.225
COTY 6.45%
$5.035
MVIS 12.96%
$1.22
ORCL -2.11%
$210.6846
JOBY 3.95%
$8.94
RUN -7.95%
$9.205
CRWV
6.55%
$156.825
RIVN 3.32%
$13.865
Discover more tools and features to empower your trading
Explore FeaturesQuotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.